A phase I/II multi-center study of Troxatyl™ in patients with refractory chronic lymphocytic leukemia (CLL), lymphoma or multiple myeloma (MM).

被引：0
|
作者：
Giles, F
Belanger, R
Toor, A
McLaughlin, P
Fayad, L
Beran, M
Albitar, M
Vose, J
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada
[3] Univ Arkansas Med Sci, Myeloma & Transplantat Ctr, Little Rock, AR 72205 USA
[4] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Nebraska, Med Ctr, Lincoln, NE 68583 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4902
引用
收藏
页码：289B / 289B
页数：1
相关论文
共 50 条
  • [41] Final Analysis of a Phase 2 Study of Lenalidomide and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
    Badoux, Xavier C.
    Keating, Michael J.
    O'Brien, Susan
    Wierda, William G.
    Faderl, Stefan
    Estrov, Zeev
    Pasia, Manolo
    Lerner, Susan
    Sargent, Rachel L.
    Kantarjian, Hagop M.
    Ferrajoli, Alessandra
    BLOOD, 2011, 118 (21) : 448 - 448
  • [42] Phase II study of Troxatyl ™ in patients with chronic myeloid leukemia in blastic phase (CML-BP).
    Giles, F
    Feldman, E
    Cortes, J
    Faderl, S
    Larson, R
    Mamus, S
    Thomas, D
    Garcia-Manero, G
    O'Brien, S
    Beran, M
    Talpaz, M
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 258B - 258B
  • [43] Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Kevin R. Kelly
    Thomas C. Shea
    André Goy
    Jesus G. Berdeja
    Craig B. Reeder
    Kevin T. McDonagh
    Xiaofei Zhou
    Hadi Danaee
    Hua Liu
    Jeffrey A. Ecsedy
    Huifeng Niu
    Ely Benaim
    Swaminathan Padmanabhan Iyer
    Investigational New Drugs, 2014, 32 : 489 - 499
  • [44] A Phase 1/2 Study of Umbralisib Ublituximab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
    Barr, Paul M.
    Hill, Brian T.
    Ma, Shuo
    Baran, Andrea M.
    Bui, Andrew
    Meacham, Philip J.
    Morrison, Ashley
    Liesveld, Jane L.
    Mulford, Deborah A.
    Sportelli, Peter
    Miskin, Hari P.
    Weiss, Michael S.
    Friedberg, Jonathan W.
    Zent, Clive S.
    BLOOD, 2019, 134
  • [45] Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updated Long Term Results of Phase II Study
    Xu, Wei
    Song, Yongping
    Wang, Tingyu
    Yang, Shenmiao
    Liu, Lihong
    Hu, Yu
    Zhang, Wei
    Zhou, Jianfeng
    Gao, Sujun
    Ding, Kaiyang
    Zhang, Huilai
    Zhu, Zunmin
    Wang, Shunqing
    Xu, Bing
    Hu, Jianda
    Liu, Ting
    Ji, Chunyan
    Xia, Zhongjun
    Li, Yan
    Wang, Xin
    Bin Zhang
    Zhao, Renbin
    Li, Jianyong
    BLOOD, 2021, 138
  • [46] Phase-II-study of rituximab in combination with fludarabine in patients (pts) with chronic lymphocytic leukemia (CLL).
    Schulz, H
    Klein, SK
    Rehwald, U
    Reiser, M
    Ibach, S
    Aulitzky, WE
    Hensel, M
    Herold, M
    Huhn, D
    Knauf, U
    Hallek, M
    Diehl, V
    Engert, A
    BLOOD, 2001, 98 (11) : 364A - 364A
  • [47] Phase I/II Dose Expansion Of a Multi-Center Trial Of Carfilzomib and Pomalidomide With Dexamethasone (Car-Pom-d) In Patients With Relapsed/Refractory Multiple Myeloma
    Shah, Jatin J.
    Stadtmauer, Edward A.
    Abonour, Rafat
    Cohen, Adam D.
    Bensinger, William
    Gasparetto, Cristina
    Kaufman, Jonathan L.
    Lentzsch, Suzanne
    Vogl, Dan T.
    Orlowski, Robert Z.
    Kim, Erica L.
    Bialas, Natalia
    Smith, David D.
    Durie, Brian G. M.
    BLOOD, 2013, 122 (21)
  • [48] A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
    Hijiya, N.
    Gaynon, P.
    Barry, E.
    Silverman, L.
    Thomson, B.
    Chu, R.
    Cooper, T.
    Kadota, R.
    Rytting, M.
    Steinherz, P.
    Shen, V.
    Jeha, S.
    Abichandani, R.
    Carroll, W. L.
    LEUKEMIA, 2009, 23 (12) : 2259 - 2264
  • [49] A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
    N Hijiya
    P Gaynon
    E Barry
    L Silverman
    B Thomson
    R Chu
    T Cooper
    R Kadota
    M Rytting
    P Steinherz
    V Shen
    S Jeha
    R Abichandani
    W L Carroll
    Leukemia, 2009, 23 : 2259 - 2264
  • [50] Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial
    Amrein, Philip C.
    Attar, Eyal
    Takvorian, Tak
    Hochberg, Ephraim
    Ballen, Karen K.
    Leahy, Kathleen M.
    Neuberg, Donna
    Brown, Jennifer R.
    BLOOD, 2008, 112 (11) : 1084 - 1084
12345